2019-09-01
Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply
Publication
Publication
Journal of Clinical Oncology , Volume 37 - Issue 25 p. 2294- +
Additional Metadata | |
---|---|
doi.org/10.1200/jco.19.01208, hdl.handle.net/1765/121020 | |
Journal of Clinical Oncology | |
Organisation | Department of Pulmonology |
Fennell, D.A., Taylor, P., Gilligan, D., Nakano, Y., Scherpereel, A, Pavlakis, N., … Baas, P. (2019). Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply. Journal of Clinical Oncology, 37(25), 2294–+. doi:10.1200/jco.19.01208 |